Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
28.86
+0.30 (1.03%)
At close: Apr 14, 2026, 4:00 PM EDT
28.88
+0.02 (0.09%)
After-hours: Apr 14, 2026, 4:10 PM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.92 billion as of April 14, 2026. Its market cap has increased by 14.11% in one year.
Market Cap
1.92B
Enterprise Value
-1.61B
1-Year Change
14.11%
Ranking
Category
Stock Price
$28.86
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $1.92B, an increase of 2.91%. That is a compound annual growth rate of 0.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.88B | -12.66% |
| Dec 31, 2025 | 2.15B | 18.91% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
| May 14, 2015 | 1.86B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 2.03B |
| AnaptysBio | 2.02B |
| Adaptive Biotechnologies | 1.97B |
| Mesoblast | 1.94B |
| Zymeworks | 1.94B |
| Agios Pharmaceuticals | 1.93B |
| Ocular Therapeutix | 1.91B |
| Tyra Biosciences | 1.90B |